News
News releases on March 10, 2024
Every news release public companies put out on March 10, 2024 (UTC): 15 news releases, newest first. Open any release to read it.
Línea Directa Aseguradora S A Compañía de Seguros y Reaseguros: Línea Directa launches its Personal Mobility Insurance under its brand
Linea Directa Aseguradora SA · Mar 10, 2024
Press Release Mar 10 2024
NLC India Limited · Mar 10, 2024
Press Release Mar 10 2024
SJVN Limited · Mar 10, 2024
Press Release Mar 10 2024
Gensol Engineering Limited · Mar 10, 2024
Press Release Mar 10 2024
Adani Enterprises Limited · Mar 10, 2024
This announcement is made in terms of Section 8 – Corporate Disclosure of the listing rules of the Colombo Stock Exchange (CSE). (the res...
Standard Capital PLC · Mar 10, 2024
Gold Stocks Could Gain In Catch-Up Rally, Says Peter Schiff: 'Explosive Move Up Can't Be Far Away'
DRDGOLD Ltd. · Mar 10, 2024
VCI Global Limited Establishes Support For Wisdom Accelerator Youth (WAY) Alongside The World Economic Forum
VCI Global Limited · Mar 10, 2024
Silvercorp Metals Clarifies OreCorp Offer Intentions
Silvercorp Metals Inc. · Mar 10, 2024
Patriot Battery Metals Announces Change of Auditor
PMET Resources Inc. · Mar 10, 2024
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other import...
MoonLake Immunotherapeutics · Mar 10, 2024
Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis
Incyte Corporation · Mar 10, 2024
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Supp...
Incyte Corporation · Mar 10, 2024
Euro Manganese Advances to Next Stage of Debt Funding Process with the European Investment Bank
Euro Manganese, Inc. · Mar 10, 2024
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 ...
Arcutis Biotherapeutics, Inc. · Mar 10, 2024